Nivolumab-Induced Organizing Pneumonia in Management of Non-small Cell Lung Carcinoma: A Case Report

Nivolumab is an immune checkpoint inhibitor (ICI) that has proven efficacy in managing certain malignancies, including non-small lung carcinoma. In this case, we present a 53-year-old female patient diagnosed with metastatic non-small lung carcinoma. After management with radiation (both external be...

Descripción completa

Detalles Bibliográficos
Autores principales: Habib, Tehmina, Abu-Abaa, Mohammad, Kolman-Taddeo, Diana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276897/
https://www.ncbi.nlm.nih.gov/pubmed/37337505
http://dx.doi.org/10.7759/cureus.39217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276897/
https://www.ncbi.nlm.nih.gov/pubmed/37337505
http://dx.doi.org/10.7759/cureus.39217

Ejemplares similares